CNBC Bill George: The VC view on drug pricing

James Thornton, venture capital investor, discusses Mylan CEO Heather Breschs explanation for the pricing of the EpiPen. CNBC Contributor Bill George, .
Sen. Charles Grassley (R-Iowa), reacts to what Mylan CEO Heather Bresch had to say about the EpiPen pricing outrage. » Subscribe to CNBC: .
Bill George, Harvard Business School Senior Fellow and Former Medtronic Chairman, weighs in on Mylan CEO Heather Breschs upcoming testimony on .
Watch my appearance on CNBCs Squawk on the Street where I will discuss the latest Samsung news.